The global strategy to stop AMR or antimicrobial resistance cannot happen without adequate focus on good policies backed by strong research on containment. Timothy Jinks who heads the Drug-Resistant Infections Priority Program at Wellcome Trust, a UK-based research charity, talks to Rajeshwari Sinha about successes and challenges in coordinating AMR containment research and policy-making efforts